Preoperative management of pheochromocytoma;Medikamentose Vorbehandlung beim Phaochromozytom

Zentralblatt fur Chirurgie

Volumn 122, Issue 6, 1997, Pages 454-459

  Forster G ^a   Schulz, G ^a   Kahaly, G ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Alpha methylparatyrosine; Phenoxybenzamine; Pheochromocytoma; Prazosin; Preoperative management

Indexed keywords

METIROSINE; PHENOXYBENZAMINE; PRAZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ARTICLE; BLOOD PRESSURE REGULATION; HEMODYNAMIC MONITORING; HUMAN; PHEOCHROMOCYTOMA; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; ADRENAL TUMOR; HYPERTENSION; PEROPERATIVE COMPLICATION; PREMEDICATION; REVIEW; RISK FACTOR; URINE;

ADRENAL GLAND NEOPLASMS; ADRENERGIC ALPHA-ANTAGONISTS; CATECHOLAMINES; HUMANS; HYPERTENSION; INTRAOPERATIVE COMPLICATIONS; PHENOXYBENZAMINE; PHEOCHROMOCYTOMA; PREMEDICATION; RISK FACTORS;

EID: 0030804991     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bravo EL, Gifford RW (1984) Pheochromocytoma: diagnosis, localization and management. N Enal J Med 311: 1298-1303
2. Bravo EL, Gifford RW (1993) Pheochromocytoma. Endocrinol Metab Clin N Amer 22: 329-341
3. Casanova S, Rosenberg-Bourgin M, Farkas D, Calmettes C, Feingold N, Heshmati HM, Cohen R, Conte-Devoix B, Guillausseau PJ, Houdent C, Bigorgne JC, Boiteau V, Caron J, Modigliani E (1993) Phaeochromocytoma in multiple endocrine neoplasia type 2A. Survey of 100 cases. Clin Endocrinol 38: 531-537
4. Cubbedu LX (1988) New alpha1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance. Am Heart J 116: 133-162
5. Dabrowska B, Pruszyk P, Dabrowski A, Feltynowski T, Wocial B, Januszewicz W (1995) Influence of alpha-adrenergic blockade on vertricular arrhythmias. QTc interval and heart rate variability in phaeochromocytoma. J Hum Hypertens 9: 925-929
6. Dashwood MR (1982) Central and peripheral prazisin binding. Eur J Pharmacol 86: 51-58
7. Doi M, Ikeda K (1989) Sevoflurane anesthesia with adenosine triphosphate for resection of pheochromocytoma. Anesthesiology 70: 360-363
8. Easton DF, Ponder MA, Cumings T, Gagel RF, Hansen HH, Reichlin S, Tashjian AH, Telenius-Berg M, Ponder BAJ (1989) The clinical and screening age-at-onset distribution for the MEN-2 syndrome. Am J Hum Genet 44: 208-215
9. Favre L, Forster A, Fatki M, Vallotton MB (1986) Calcium-channel inhibition in pheochromocytoma. Acta Endocrinol 113: 385-390
10. Grosse H, Schröder D, Dralle H, Schober O, von zur Mühlen A. (1988) Phäochromozytom: Blutvolumen und Hämodynamik. Anästh Intensivth Notfallmed 23: 77-81
11. Grosse H, Schröder D, Schober O, Hausen B, Drake A (1990) Die Bedeutung einer hochdosierten Alpha-Rezeptorenblockade für Blutvolumen und Hämodynamik beim Phäochromozytom. Anästhesist 39: 313-318
12. Hull CJ (1986) Phaeochromocytoma - diagnosis, preoperative preparation and anaesthetic management. Br J Anaesth 58: 1453-1468
13. James FMM (1989) Use of magnesiumsulphate in the anaesthetic management of phaeochromocytoma: A review of 17 anaesthetics. Br J Anaesth 62: 616-623
14. Jovenich JJ (1989) Anesthesia in adrenal surgery. Urol Clin North Am 16: 583-587
15. Klein AM (1993) Phäochromozytom: Intraoperative Probleme aus anästhesiologischer Sicht. In Beyer J, Junginger T, Lehnert H, Walgenbach S (Hrsg): Diagnostische und chirurgische Aspekte bei endokrinen Erkrankungen. S 86-93. München: Sympomed
16. Knoch M (1995) Phäochromozytome - Diagnostik und Therapie aus chirurgischer Sicht. In Hensen J (Hrsg): Fortschritte in Diagnostik und Therapier endokrinologischer Erkrankungen. S 305-318. 3. Erlanger Symposium für Endokrinologie und Stoffwechsel: Netzwerk
17. Lamberts R, Kreuzer H (1996) Phäochromozytom-induziertes Multiorganversagen: Ein internistischer und chirurgischer Notfall Dtsch Med Wschr 121: 479-484
18. Larsen (1995) Anästhesie. 5. Aufl. München. Wien, Baltimore: Urban & Schwarzenberg
19. Lehnert H, Beyer J (1995) Phäochromozytom. In Dick W, Enck A, Schuster HP (Hrsg): Prä- und postoperative Behandlung. S 143-148. Stuttgart; Wissenschaftliche Verlagssesellschaft (WVG)
20. Malone MJ, Libertino JA, Tsapatsaris NP, Woods B (1989) Preoperative and surgical management of pheochromocytoma. Urol Clin North Am 16: 567-582
21. Orchard T, Grant CS, van Heerden JA, Weaver A (1993) Pheochromocytoma - continuing evolution of surgical therapy. Surgery 114: 1153-1159
22. Padberg BC, Holl K, Schröder S (1992) Pathology of multiple endocrine neoplasis 2A and 2B. A review. Horm Res 38: 24-30
23. Plouin PF, Bertherat J, Chatellier G, Billaud E, Azizi M, Grouzmann E, Epelbaum J (1995) Short term effectes of octreotide on blood presure and plasma catecholamines and neuropeptide Y levels in patients with paeochromocytoma: a placebo controlled trial. Clin Endocrinol 42: 289-294
24. Roizen MF, Horigam RW, Frazer BM (1981) Anesthetic doses blocking adrenergic (stress) and cardiovascular responses to incision. Anesthesiology 54: 390-398
25. Roizen MF (1990) Anesthetic implication of concurrent diseases. In Miller RD (Hrsg): Anesthesia. S 793-893. New York, Edinburgh, London, Melbourne, Churchill Livingstone
26. Schürmeyer TH, Dralle H, von zur Mühlen A (1993) Phaochromozytom: präoperative Diagnostik und Therapie. In Beyer J, Junginger T, Lehnert H, Walgenbach S (Hrsg): Diagnostische und chirurgische Aspekte bei endokrinen Erkrankungen. S 69-80. München: Sympomed
27. St. John Sutton MG, Sheps SG. Lie JT (1981) Prevalence of clinically unsuspected pheochromocytomy. Review of a 50-year autopsy series. Mayo Clin Proc 56: 354
28. Stenström G, Haljamäe H, Tisell LE (1985) Influence of preoperative treatment with phenoxybenzamine on the incidence of adverse cardiovascular reactions during anaesthesia and surgery for pheochromocytoma. Acta Anaesthesiol Scand 29: 797-803
29. Whalen RK. Althansen AF, Daniels GH (1992) Extraadrenal pheochromocytomas. J Urol 147: 1-10